We have located links that may give you full text access.
Outcomes and quality of life after Ross reintervention: would you make the same choice again?
Annals of Thoracic Surgery 2019 November 24
BACKGROUND: The Ross procedure was introduced as a long term if not definitive solution for aortic pathology. However, the rate of reoperation is not negligible.
METHODS: Single center prospective study assessing the general outcome of Ross reoperation and patients perceived quality of life compared with two control groups (Ross non reoperation and mechanical aortic valve replacement). Patient's preference, regarding the choice between mechanical aortic valve and Ross procedure, was investigated in a subgroup who could theoretically have been directed to either of the two procedures.
RESULTS: Between 2005 and 2017, 64 consecutive patients underwent reoperation after Ross. Median age was 31 years. Median freedom from reoperation after Ross procedure was 136 months. Forty-nine patients required autograft reoperation and 25 had homograft failure. No in-hospital mortality was recorded. Mean follow-up was 77 months(range 6-164). Short Form Health Survey (SF-36) questionnaire was administered, to assess the quality of life. Ross reoperation group showed a lower score involving psychological concerns compared to other groups. In reoperated patients group, 52 had adequate aortic annulus dimensions to receive a prosthetic valve instead of a Ross procedure. When asked if they would make the same choice, only 31% confirmed the preference.
CONCLUSIONS: Reoperations after Ross procedure have low mortality and morbidity. Long-term follow-up showed a high quality of life, even after reoperations. However, due to psychological concerns following redo surgery, when choosing a Ross procedure, it is our duty to thoroughly explain to patients that in case of reoperations a high level of disillusion is predictable.
METHODS: Single center prospective study assessing the general outcome of Ross reoperation and patients perceived quality of life compared with two control groups (Ross non reoperation and mechanical aortic valve replacement). Patient's preference, regarding the choice between mechanical aortic valve and Ross procedure, was investigated in a subgroup who could theoretically have been directed to either of the two procedures.
RESULTS: Between 2005 and 2017, 64 consecutive patients underwent reoperation after Ross. Median age was 31 years. Median freedom from reoperation after Ross procedure was 136 months. Forty-nine patients required autograft reoperation and 25 had homograft failure. No in-hospital mortality was recorded. Mean follow-up was 77 months(range 6-164). Short Form Health Survey (SF-36) questionnaire was administered, to assess the quality of life. Ross reoperation group showed a lower score involving psychological concerns compared to other groups. In reoperated patients group, 52 had adequate aortic annulus dimensions to receive a prosthetic valve instead of a Ross procedure. When asked if they would make the same choice, only 31% confirmed the preference.
CONCLUSIONS: Reoperations after Ross procedure have low mortality and morbidity. Long-term follow-up showed a high quality of life, even after reoperations. However, due to psychological concerns following redo surgery, when choosing a Ross procedure, it is our duty to thoroughly explain to patients that in case of reoperations a high level of disillusion is predictable.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app